U.S. Retail REITs Stock News

NYSE:IBM
NYSE:IBMIT

IBM (IBM) Stock Stays Reasonable On Earnings While Cash Flow Looks Rich

International Business Machines stock has dropped sharply in recent weeks, yet valuation checks suggest the current US$211.20 share price may sit below what its fundamentals imply, with both the intrinsic value estimate from a Discounted Cash Flow (DCF) approach and earnings multiples pointing in the same direction. Over 5 years, International Business Machines has returned about 90.3%, which puts the recent pullback in the context of a long, solid run for holders who stayed invested. On the...
NasdaqGS:QRVO
NasdaqGS:QRVOSemiconductor

Qorvo (QRVO) Stock May Be 11% Undervalued On A Supply Deal

Qorvo stock has fallen about 57% over the past five years, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and the market based valuation checks currently point to the shares trading below what the underlying business may justify. Qorvo's share price is down roughly 57% over five years, which sets expectations low and makes the current valuation especially important to scrutinize. The new distribution agreement with Rochester Electronics can support long term demand and cash...
NasdaqGS:BATR.K
NasdaqGS:BATR.KEntertainment

What Atlanta Braves Holdings (BATR.K)'s Padres Valuation Gap Moment Means For Shareholders

In the recent quarter, Longleaf Partners Small-Cap Fund highlighted Atlanta Braves Holdings, Inc. after the Padres franchise sold at a revenue multiple higher than that implied for the Braves, while operations at The Battery and the team’s on-field start remained strong. This combination of richer peer transaction pricing, resilient real estate performance, and competitive play underscores how both on-field results and off-field assets can shape investor perceptions of the franchise’s...
NasdaqGS:ONC
NasdaqGS:ONCBiotechs

BeOne Medicines (ONC) Stock Looks Expensive Even With Strong Pipeline Hopes

BeOne Medicines has delivered a 61.1% return over the past three years, yet its current valuation screens as overvalued on market multiples and only middling on broader checks. This raises the question of how much optimism is already reflected in the share price. A 61.1% three year return suggests investors have already priced in a meaningful amount of good news for BeOne Medicines. Recent analyst upgrades tied to the chronic lymphocytic leukemia franchise and solid tumor pipeline can...
NasdaqGS:APP
NasdaqGS:APPSoftware

AppLovin (APP) Is Down 13.3% After AI Pivot Meets Geopolitics-Driven Pullback Ahead Q2 Earnings

In the past week, AppLovin’s shares extended a multi-day slide amid a broader market pullback linked to renewed US–Iran tensions, just weeks before its Q2 2026 earnings release on August 5. This volatility comes as investors reassess AppLovin’s shift into a pure-play AI-driven advertising platform after exiting mobile gaming, spotlighting its unusually high reported margins and business transformation. With that backdrop, we’ll examine how AppLovin’s pivot to an AI-focused ad platform...
NYSE:MOG.A
NYSE:MOG.AAerospace & Defense

GE Aerospace Stock And 2 Defense Names Backed By Long Term Spending

With inflation signals mixed, bond yields on the move and global trade tensions in focus, many investors are looking for sectors that are closely tied to long term government priorities and national security. The Aerospace And Defense screener groups companies that manufacture or provide services to this space, giving you a targeted way to look at stocks that sit at the crossroads of government budgets, industrial activity and technology. In this article, you will see 3 stocks from the...
NYSE:AUB
NYSE:AUBBanks

Is Atlantic Union Bankshares (AUB) Undervalued As Q2 Earnings Concerns Build?

Atlantic Union Bankshares earnings event puts focus on expectations Atlantic Union Bankshares (AUB) heads into its July 21 Q2 2026 earnings release with analysts flagging potential year over year softness in both earnings and revenue, setting a cautious tone around the stock. See our latest analysis for Atlantic Union Bankshares. Despite the cautious earnings setup, Atlantic Union Bankshares has seen firm share price momentum, with a 30-day share price return of 7.08% and a year to date share...
NYSE:CCI
NYSE:CCISpecialized REITs

Crown Castle (CCI) Stock Could Be Cheap On Cash Flow But Full On Earnings

Crown Castle stock has fallen sharply over the past five years, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to the shares trading at a discount to fundamentals, setting up a clear valuation debate after a difficult stretch for investors. Crown Castle's share price has declined 49.7% over the past five years, which means anyone who bought and held through this period has seen a substantial capital loss that now frames how attractive...
NasdaqGS:FLNC
NasdaqGS:FLNCElectrical

Fluence Energy (FLNC) Wins Avantus Deal, Is The Stock Trading At A 17% Discount?

Event overview and why Fluence Energy stock is back in focus Fluence Energy (FLNC) is back on many watchlists after agreeing to supply its Smartstack storage system and turnkey EPC services for Avantus's Rexford 2 project in California, a 200 MW / 800 MWh solar paired battery installation. The project will use 4 hour duration Smartstack units with U.S. domestic content sourced through Fluence Energy's partner manufacturing network in Utah, South Carolina, and Texas. Construction is planned to...
NasdaqGS:URBN
NasdaqGS:URBNSpecialty Retail

Urban Outfitters (URBN) Yes Day Beauty Deal Keeps Its $84 Fair Value Narrative In View

Urban Outfitters (URBN) has drawn fresh attention after announcing an exclusive U.S. brick-and-mortar partnership with emerging skincare label Yes Day Beauty, with the brand rolling out across 60 stores and online. See our latest analysis for Urban Outfitters. The Yes Day Beauty launch comes as Urban Outfitters’ short term share price performance has been mixed, with a 7 day share price return of 7.25% but a 30 day share price return that is down 5.27%. The current share price of $72.95 sits...
NYSE:LLY
NYSE:LLYPharmaceuticals

Eli Lilly (LLY) Stock May Be Below Fair Value After FDA Cancer Drug Approval

Eli Lilly stock has delivered a very large 5-year return, yet the current checks send a mixed signal, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to upside while the broader valuation score leans expensive. Eli Lilly has returned about 4.1x over the past 5 years, which puts more pressure on today’s valuation to be supported by future cash flows. Expectations around obesity and oncology drug growth can support the current price, while ongoing regulatory and pricing...
NYSE:DINO
NYSE:DINOOil and Gas

Does HF Sinclair (DINO)’s New Leadership Structure Reveal a Deeper Shift in Its Growth Playbook?

Earlier this month, HF Sinclair Corporation reshaped its leadership team by appointing Steven Ledbetter as President and COO and naming Valerie Pompa President, Growth, Technology and Transformation, while CEO Franklin Myers temporarily relinquished the President title. The decision to elevate leaders with extensive refining, midstream and operational backgrounds, while keeping Lubricants & Specialties reporting directly to the CEO, highlights HF Sinclair’s focus on execution, growth...
NasdaqCM:EOSE
NasdaqCM:EOSEElectrical

Eos Energy Enterprises (EOSE) Lands Pentagon Storage Contract For Golden Dome

Eos Energy Enterprises secured a contract with the U.S. Department of War to deploy its American-made Z3 zinc-based long-duration energy storage technology. The project will support the Golden Dome for America national defense initiative focused on grid resilience and critical infrastructure. The agreement places Eos technology within U.S. defense and energy supply chains under a government-backed program. Eos Energy Enterprises, listed as NasdaqCM:EOSE, is moving into a new arena with this...
NYSE:ENVA
NYSE:ENVAConsumer Finance

Has Enova International (ENVA) Run Ahead Of Fair Value After Its Board Changes?

Enova International (ENVA) has seen a series of governance updates in July, including director resignations, a new board appointment and fresh committee responsibilities, putting board composition in focus for shareholders. See our latest analysis for Enova International. Enova International’s recent boardroom changes come at a time when momentum in the stock has been strong, with a 30 day share price return of 24.58% and a year to date share price return of 45.51%. The 1 year total...
NYSE:AMP
NYSE:AMPCapital Markets

Ameriprise Financial (AMP) Launches New ETFs As Raymond James Advisory Team Joins

Columbia Threadneedle, part of Ameriprise Financial, has launched new actively managed ETFs focused on premium income and derivative income strategies. Johnson Stivender Wealth Advisors, a large advisory team previously at Raymond James, has joined the Ameriprise Financial platform. Ameriprise Financial (NYSE:AMP) is adding fresh product options and more advisor capacity at the same time, giving investors and clients additional ways to access its platform. The stock recently closed at...
NasdaqGS:HUT
NasdaqGS:HUTSoftware

Hut 8 (HUT) Following Benchmark Upgrade And AI Leases Looks Cheap Or Priced In

Benchmark’s recent upgrade of Hut 8 (HUT) has drawn fresh attention to the stock, after the company reported very large year over year revenue growth and signed long term A.I. focused data center leases. See our latest analysis for Hut 8. Despite the Benchmark upgrade and new A.I. data center leases, Hut 8’s 30-day share price return is down 14.27%, while the 90-day share price return is 45.28% and the year-to-date share price return is 100.96%. Over the past year, total shareholder return is...
NYSE:GOLD
NYSE:GOLDRetail Distributors

The Bull Case For Gold.com (GOLD) Could Change Following Inflation-Driven Gold Surge And Steady EPS Forecasts

Earlier this week, Gold.com’s latest trading session saw it outperform the broader market as investors focused on its upcoming financial results and analyst expectations for a significantly higher year-on-year EPS. What stands out is that analyst EPS estimates have remained stable over the past month, suggesting expectations were already calibrated before this recent attention on the company’s earnings outlook. Now we’ll examine how the recent inflation-driven surge in gold prices may...
NYSE:DT
NYSE:DTSoftware

Does Dynatrace’s Renewed Gartner Leadership in AI Observability Deepen Its Moat in Regulated Markets (DT)?

In early July 2026, Dynatrace was again named a Leader in the Gartner Magic Quadrant for Observability Platforms for the 16th consecutive time, reinforcing its role in end-to-end observability for complex AI-powered infrastructures. This long-running recognition, alongside its push toward higher government security standards such as FedRAMP High, underscores how deeply embedded Dynatrace’s platform has become in highly regulated, data-sensitive environments. We’ll now examine how Dynatrace’s...
NasdaqGS:OTEX
NasdaqGS:OTEXSoftware

Open Text (OTEX) Stock Looks Undervalued On Earnings But Weak On Returns

Open Text stock is coming off a multiyear stretch of weak returns, yet its valuation checks suggest the shares may now sit on the inexpensive side of the ledger. Over the past 5 years, Open Text shareholders have seen the stock decline 47.9%, which raises the question of whether sentiment has become too pessimistic relative to the underlying business. The company is working to embed AI across its enterprise software platform and integrate past acquisitions, which can support revenue and...
NYSE:RDN
NYSE:RDNDiversified Financial

Financial Stocks Retail Investors Are Watching As Rate Hike Fears Ease

Cooling inflation and reduced expectations for near term rate hikes have shifted attention back to large financial stocks that may be better positioned for stable economic conditions and moderate interest rate moves. With June CPI at 3.5% and core inflation at 2.6%, traders now see a lower probability of aggressive Federal Reserve action, which can influence how investors think about banks, insurers, and diversified financial companies. This article highlights 3 stocks from the Financial...
NYSE:TE
NYSE:TESemiconductor

Is T1 Energy’s (TE) Aggressive Renewable Buildout Reframing Its High-Risk Speculative Profile?

T1 Energy recently announced a major renewable infrastructure expansion plan, aiming to scale its solar and battery-related capabilities across core markets. This push to build out infrastructure comes as the company continues to operate with negative margins and substantial losses, keeping interest firmly in higher-risk, speculative territory. Next, we'll examine how this renewed infrastructure build-out could influence T1 Energy's existing investment narrative and future...
NasdaqGS:UPWK
NasdaqGS:UPWKProfessional Services

Upwork (UPWK) Sees Freelance AI Work Rise, Is The Upside Already Priced In?

Upwork (UPWK) released its second annual Future Workforce Index 2026, highlighting that the share of skilled U.S. knowledge workers freelancing rose from 28% to 38% in one year, as AI-driven roles like “AI Orchestrators” gain traction. See our latest analysis for Upwork. For investors, the Future Workforce Index arrives as Upwork’s share price sits at US$9.24, with a 7 day share price return of 7.94% and a 30 day share price return of 8.96%. The year to date share price return is down 53.43%...
NasdaqGS:BMRN
NasdaqGS:BMRNBiotechs

BioMarin (BMRN) Wins FDA Review For VOXZOGO Full Approval In Achondroplasia

FDA accepts BioMarin Pharmaceutical's supplemental New Drug Application for VOXZOGO for children with achondroplasia. Submission is based on extensive long-term safety and efficacy data from VOXZOGO treatment. The filing aims to convert VOXZOGO's existing authorization into full approval and address a major post marketing requirement. For BioMarin Pharmaceutical (NasdaqGS:BMRN), the FDA's acceptance of the VOXZOGO sNDA centers attention on its rare disease focus and its role in...